-
公开(公告)号:NZ545421A
公开(公告)日:2010-03-26
申请号:NZ54542104
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: JURCAK JOHN GERARD , BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , WEINTRAUB PHILIP MARVIN , DU YAN , DHARANIPRAGADA RAMALINGA M , PARKAR ASHFAQ AHMED
IPC: C07D495/04 , A61P11/06 , C07D519/00
Abstract: Disclosed is a compound of formula I wherein X is N, or C-R7; X1 is N, or C-R1 and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula I in the manufacture of a medicament for treating a patient with a pathological condition related to overproduction of Th2 cytokine, such as asthma.
-
公开(公告)号:BRPI0414215A
公开(公告)日:2006-11-07
申请号:BRPI0414215
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: JURCAK GERARD JOHN , BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , WEINTRAUB PHILIP MARVIN , DU YAN , DHARANIPRAGADA RAMALINGA M , PARKAR ASHFAP AHMED
IPC: C07D495/04 , C07D519/00
Abstract: Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
-
公开(公告)号:ECSP066411A
公开(公告)日:2006-09-18
申请号:ECSP066411
申请日:2006-03-06
Applicant: AVENTIS PHARMA INC
Inventor: JURCAK JOHN GERARD , BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , WEINTRAUB PHILIP MARVIN , DU YAN , DHARANIPRAGADA RAMALINGA M , PARKAR ASHFAQ AHMED
IPC: C07D495/04 , C07D519/00
Abstract: Tienopirazoles, su preparación, composiciones farmacéuticas que comprenden estos compuestos, y sus usos farmacéuticos en el tratamiento de estados de enfermedad capaces de ser modulados por la inhibición de las proteína quinasas, en particular la tirosina quinasa inducible por interleuquina-2 (ITK).
-
公开(公告)号:AU2004272507B2
公开(公告)日:2011-05-12
申请号:AU2004272507
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: DHARANIPRAGADA RAMALINGA M , BARRAGUE MATTHIEU , DU YAN , MUSICK KWON YON , PARKAR ASHFAQ AHMED , EDWARDS MICHAEL LOUIS , JURCAK JOHN GERARD , GILLESPY TIMOTHY ALAN , WEINTRAUB PHILIP MARVIN
IPC: C07D495/04 , C07D519/00
Abstract: Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
-
公开(公告)号:PL1682553T3
公开(公告)日:2010-10-29
申请号:PL04779049
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: JURCAK JOHN GERARD , BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , WEINTRAUB PHILIP MARVIN , DU YAN , DHARANIPRAGADA RAMALINGA M , PARKAR ASHFAQ AHMED
IPC: C07D495/04 , C07D519/00
-
公开(公告)号:RS20060162A
公开(公告)日:2008-06-05
申请号:YUP20060162
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: JURCAK JOHN GERARD , BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , DU YAN , DHARANIPRAGADA RAMALINGA , PARKAR ASHFAQ AHMED , WEINTRAUB PHILIP MARVIN
IPC: C07D495/04 , C07D519/00
Abstract: Tienopirazoli, njihova priprema, farmaceutski preparati koji sadrže ova jedinjenja, i njihova farmaceutsko upotreba u lečenju bolesnih stanja koja se mogu menjati inhibicijom protein kinaze, naročito tirozin kinaze koja se može indukovati interleukinom-2.
-
公开(公告)号:BRPI0509391A
公开(公告)日:2007-09-18
申请号:BRPI0509391
申请日:2005-03-29
Applicant: AVENTIS PHARMA INC
Inventor: WEINTRAUB PHILIP MARVIN , EASTWOOD PAUL R , MEHDI SHUJAATH , STEFANY DAVID W , MUSICK KWON YON , MOORCROFT NEIL , LIM SUNGTAEK , JIANG JOHN Z , RUTTEN HARTMUT , PEUKERT STEFAN , SCHWAHN UWE
IPC: C07D213/62 , A61K31/44 , A61P9/00 , C07D213/64 , C07D217/24 , C07D401/04 , C07D401/14 , C07D405/04 , C07D409/04 , C07D409/14 , C07D413/04 , C07D417/14
Abstract: The present invention relates to a series of 2,3,5-substituted pyridone derivatives of formula I: wherein R, R1, R2, R3 and R4 are as defined herein. This invention also relates to methods of making these compounds. The compounds of this invention are inhibitors of poly(adenosine 5′-diphosphate ribose) polymerase (PARP) and are therefore useful as pharmaceutical agents, especially in the treatment and/or prevention of a variety of diseases, including diseases associated with the central nervous system and cardiovascular disorders.
-
公开(公告)号:CA2538032A1
公开(公告)日:2005-03-24
申请号:CA2538032
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , JURCAK JOHN GERARD , DHARANIPRAGADA RAMALINGA M , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , DU YAN , WEINTRAUB PHILIP MARVIN , PARKAR ASHFAQ AHMED
IPC: C07D495/04 , C07D519/00
Abstract: Thienopyrazoles, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
-
公开(公告)号:AU2004272507A1
公开(公告)日:2005-03-24
申请号:AU2004272507
申请日:2004-07-23
Applicant: AVENTIS PHARMA INC
Inventor: DHARANIPRAGADA RAMALINGA M , BARRAGUE MATTHIEU , DU YAN , MUSICK KWON YON , PARKAR ASHFAQ AHMED , EDWARDS MICHAEL LOUIS , JURCAK JOHN GERARD , GILLESPY TIMOTHY ALAN , WEINTRAUB PHILIP MARVIN
IPC: C07D495/04 , C07D519/00
Abstract: Thienopyrazoles of formula I, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
-
公开(公告)号:CY1110743T1
公开(公告)日:2015-06-10
申请号:CY101100762
申请日:2010-08-17
Applicant: AVENTIS PHARMA INC
Inventor: JURCAK JOHN GERARD , BARRAGUE MATTHIEU , GILLESPY TIMOTHY ALAN , EDWARDS MICHAEL LOUIS , MUSICK KWON YON , WEINTRAUB PHILIP MARVIN , DU YAN , DHARANIPRAGADA RAMALINGA M , PARKAR ASHFAQ AHMED
IPC: C07D495/04
Abstract: Θειενοπυραζόλια, ηπαρασκευήτους, φαρμακευτικέςσυνθέσειςπουπεριέχουντιςενλόγωενώσειςκαιοιφαρμακευτικέςτουςχρήσειςστηθεραπευτικήαντιμετώπισηπαθήσεωνπουείναισεθέσηναρυθμιστούνδιατηςαναστολήςπρωτεϊνικώνκινασών, ιδίωςτηςεπαγώγιμηςδιαιντελευκίνης-2 τυροσινικήςκινάσης (ΙΤΚ).
-
-
-
-
-
-
-
-
-